Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
Melanoma News
Publication date: May 13, 2022 Malignant melanoma is one of the most common types of cancer in the United States. Despite recent and well-described progress in melanoma treatment, advanced disease ... Read more